February 6, 2020
After identifying a molecular pathway that allows nonalcoholic steatohepatitis (NASH) to progress into liver cell death, University of California San Diego School of Medicine researchers were able to use these pathways to halt further liver damage.
November 17, 2014
Triclosan is an antimicrobial commonly found in soaps, shampoos, toothpastes and many other household items. Despite its widespread use, researchers at University of California, San Diego School of Medicine report potentially serious consequences of long-term exposure to the chemical.
January 23, 2012
…Health System has received approval to acquire the Nevada Cancer Institute (NVCI), the official cancer institute of the state of Nevada, as an affiliate health care provider. The expansion represents a partnership between California and Nevada in offering lifesaving cancer care to patients through expert diagnosis, novel treatments and clinical…
April 2, 2015
Cells of the intestine, liver and pancreas are difficult to produce from stem cells. Writing in Cell Stem Cell April 2, researchers at University of California, San Diego School of Medicine have discovered that chromosomes in laboratory stem cells open slowly over time, in the same sequence that occurs during…
October 15, 2019
UC San Diego bioengineers are a step closer to making CAR T-cell therapy safer, more precise and easy to control. They developed a system that allows them to select where and when CAR T cells get turned on so that they destroy cancer cells without harming normal cells.
April 15, 2014
Researchers at the University of California, San Diego School of Medicine have identified a mechanism that explains why people with the hepatitis C virus get liver disease and why the virus is able to persist in the body for so long.
October 11, 2016
Combining multiple non-invasive measures, researchers at University of California San Diego School of Medicine describe a novel method to quantify the progression of nonalcoholic fatty liver disease (NAFLD) to its more dangerous and deadly states — advanced fibrosis and cirrhosis.
August 23, 2023
$9 million grant awarded to researchers with UC San Diego School of Medicine supports new study of semaglutide for liver disease.
September 29, 2022
An international team of scientists, co-led by researchers at the University of California San Diego School of Medicine, has created the first pan-cancer mycobiome atlas—a survey of 35 types of cancer and their associated fungi.
March 19, 2012
…affects some 170 million people worldwide and causes chronic liver disease and liver cancer.
